639 related articles for article (PubMed ID: 25536148)
1. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
[TBL] [Abstract][Full Text] [Related]
2. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.
Arai M; Ikawa Y; Chujo S; Hamaguchi Y; Ishida W; Shirasaki F; Hasegawa M; Mukaida N; Fujimoto M; Takehara K
J Dermatol Sci; 2013 Mar; 69(3):250-8. PubMed ID: 23142052
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
[TBL] [Abstract][Full Text] [Related]
5. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
[TBL] [Abstract][Full Text] [Related]
6. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
Hartwig T; Montinaro A; von Karstedt S; Sevko A; Surinova S; Chakravarthy A; Taraborrelli L; Draber P; Lafont E; Arce Vargas F; El-Bahrawy MA; Quezada SA; Walczak H
Mol Cell; 2017 Feb; 65(4):730-742.e5. PubMed ID: 28212753
[TBL] [Abstract][Full Text] [Related]
7. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
8. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
[TBL] [Abstract][Full Text] [Related]
9. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
10. Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization.
Lu P; Li L; Liu G; van Rooijen N; Mukaida N; Zhang X
Cornea; 2009 Jun; 28(5):562-9. PubMed ID: 19421039
[TBL] [Abstract][Full Text] [Related]
11. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
[TBL] [Abstract][Full Text] [Related]
12. Expression of MCP-1 and fractalkine on endothelial cells and astrocytes may contribute to the invasion and migration of brain macrophages in ischemic rat brain lesions.
Tei N; Tanaka J; Sugimoto K; Nishihara T; Nishioka R; Takahashi H; Yano H; Matsumoto S; Ohue S; Watanabe H; Kumon Y; Ohnishi T
J Neurosci Res; 2013 May; 91(5):681-93. PubMed ID: 23400803
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.
Wei LM; Cao S; Yu WD; Liu YL; Wang JT
Oncol Rep; 2015 Feb; 33(2):615-24. PubMed ID: 25482732
[TBL] [Abstract][Full Text] [Related]
14. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
Peng X; Zhang J; Xiao Z; Dong Y; Du J
J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
[TBL] [Abstract][Full Text] [Related]
15. Implications for the role of macrophages in a model of myocardial fibrosis: CCR2(-/-) mice exhibit an M2 phenotypic shift in resident cardiac macrophages.
Falkenham A; Myers T; Wong C; Legare JF
Cardiovasc Pathol; 2016; 25(5):390-8. PubMed ID: 27327107
[TBL] [Abstract][Full Text] [Related]
16. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
17. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
18. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
[TBL] [Abstract][Full Text] [Related]
19. Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis.
Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
Dig Dis Sci; 2014 Feb; 59(2):358-64. PubMed ID: 24185682
[TBL] [Abstract][Full Text] [Related]
20. Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
An J; Xue Y; Long M; Zhang G; Zhang J; Su H
Oncotarget; 2017 Jun; 8(24):39230-39240. PubMed ID: 28424406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
